Schedule I Copyright Infringement Accuser Gets Review Bombed Instead

The indie game Schedule I, a co-op crime simulation where players climb from small-time dope pushers to kingpins, has found itself at the center of a copyright infringement controversy. Movie Games S.A., the developers behind the The Drug Dealer Simulator series, have accused Schedule I of copying plot elements, mechanics, and even the user interface from their games. This accusation was reported by the Polish Press Agency on April 3, following a legal analysis by Movie Games S.A., suggesting that Schedule I may have infringed on their intellectual property rights.

Although no official outcomes from the investigation have been announced, fans have taken sides, with a significant number supporting Schedule I. In a surprising turn of events, The Drug Dealer Simulator and Drug Dealer Simulator 2 have been hit with a wave of negative reviews on Steam, now marked as "Overwhelmingly Negative" and "Mostly Negative" respectively. The backlash primarily focuses on Movie Games S.A.'s perceived bullying of the indie developer and their apparent hypocrisy, as similar games had been released without challenge until Schedule I came along. Despite this, the Drug Dealer Simulator series has been widely acclaimed as one of the top criminal management games by both critics and fans.

Schedule I Recent Updates

Schedule I’s Copyright Infringement Accuser Gets Review Bombed on Steam

Schedule I, launched into Early Access on PC on March 25, has quickly risen to become Steam’s 2nd top-selling game, outperforming notable titles such as inZOI, Monster Hunter Wilds, and the indie game R.E.P.O.. With an all-time peak of 459,075 concurrent players according to SteamDB, Schedule I has garnered "Overwhelmingly Positive" reviews. At Game8, we found Schedule I to be an unexpectedly addictive and rewarding experience, akin to a "Breaking Bad" simulator. For a deeper dive into our impressions of the early access release, feel free to explore our detailed article below.